Abbott Laboratories (ABT)

Precedente Chiudi:

$105.97

Aprire:

$105.93

Volume 24 ore:

4.03M

Capitalizzazione di mercato:

$184.43B

Reddito:

$40.33B

Utile/perdita netta:

$5.63B

Rapporto P/E:

36.15

EPS:

2.94

Flusso di cassa netto:

$5.06B

1 W Prestazione:

-0.56%

1M Prestazione:

-5.17%

6M Prestazione:

+11.87%

1 anno Prestazione:

-4.34%

Intervallo 1D:

$105.91

$107.16

Portata 52W:

$89.67

$121.64

Abbott Laboratories Stock (ABT) Company Profile

Nome

Abbott Laboratories

Settore

Healthcare (1189)

Industria

Medical Devices (158)

Telefono

224-667-6100

Indirizzo

100 Abbott Park Road, Abbott Park, IL

Dipendente

99,000

Cinguettio

@AbbottNews

Prossima data di guadagno

2024-04-26

Ultimi documenti SEC

ABT's Discussions on Twitter

Abbott Laboratories Stock (ABT) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-07-21	Aggiornamento	Wolfe Research	Underperform → Peer Perform
2023-05-30	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2023-04-20	Reiterato	Barclays	Overweight
2023-04-20	Reiterato	Bernstein	Outperform
2023-04-20	Reiterato	JP Morgan	Overweight
2023-04-20	Reiterato	Raymond James	Outperform
2023-04-20	Reiterato	UBS	Buy
2023-04-20	Reiterato	Wolfe Research	Underperform
2023-03-29	Iniziato	UBS	Buy
2022-10-26	Iniziato	Mizuho	Neutral
2022-10-18	Iniziato	Barclays	Overweight
2022-10-12	Iniziato	Jefferies	Hold
2022-07-06	Iniziato	Wolfe Research	Underperform
2022-03-02	Ripresa	BofA Securities	Buy
2022-01-27	Reiterato	Credit Suisse	Outperform
2022-01-27	Reiterato	Morgan Stanley	Overweight
2022-01-27	Reiterato	Raymond James	Outperform
2022-01-27	Reiterato	UBS	Buy
2021-12-10	Iniziato	RBC Capital Mkts	Outperform
2021-10-27	Aggiornamento	Atlantic Equities	Neutral → Overweight
2021-10-14	Iniziato	Redburn	Neutral
2021-05-25	Iniziato	Barclays	Overweight
2021-04-15	Iniziato	Atlantic Equities	Neutral
2021-01-28	Aggiornamento	BTIG Research	Neutral → Buy
2020-09-11	Iniziato	Wolfe Research	Outperform
2020-06-01	Downgrade	Goldman	Neutral → Sell
2020-03-05	Iniziato	Citigroup	Buy
2020-02-13	Iniziato	Goldman	Neutral
2020-02-06	Ripresa	BTIG Research	Neutral
2020-01-02	Downgrade	Guggenheim	Buy → Neutral
2019-06-13	Reiterato	BofA/Merrill	Buy
2019-02-07	Reiterato	BofA/Merrill	Buy
2019-01-02	Downgrade	Citigroup	Neutral → Sell
2018-11-30	Aggiornamento	Goldman	Neutral → Buy
2018-10-16	Iniziato	Barclays	Overweight
2018-06-27	Iniziato	Bernstein	Outperform
2018-01-30	Reiterato	Citigroup	Neutral
2018-01-25	Reiterato	Stifel	Buy
2018-01-25	Aggiornamento	William Blair	Mkt Perform → Outperform
2018-01-03	Iniziato	Evercore ISI	Outperform
2018-01-02	Aggiornamento	JP Morgan	Neutral → Overweight
2018-01-02	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2017-10-19	Reiterato	RBC Capital Mkts	Outperform
2017-10-19	Reiterato	Stifel	Buy

Mostra tutto

Abbott Laboratories Borsa (ABT) Ultime notizie

Is Trending Stock Abbott Laboratories (ABT) a Buy Now?

Zacks Investment Research

PBH vs. ABT: Which Stock Is the Better Value Option?

Zacks Investment Research

2 Beaten-Down Dividend Stocks to Buy and Hold Forever

The Motley Fool

Better Dividend Stock: AbbVie or Johnson & Johnson?

The Motley Fool

3 Dividend Stocks to Buy and Hold for the Next Decade

The Motley Fool

Is ProShares S&P 500 Dividend Aristocrats ETF (NOBL) a Strong ETF Right Now?

Zacks Investment Research

Abbott Laboratories Azioni (ABT) Dati Finanziari

Abbott Laboratories (ABT) Reddito 2024

Abbott Laboratories (ABT) Reddito netto 2024

Abbott Laboratories (ABT) Flusso di cassa 2024

Abbott Laboratories (ABT) Utile per azione 2024

Abbott Laboratories Azioni (ABT) insider trading